{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:33:24Z","timestamp":1793392404413,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP08\/00140"],"award-info":[{"award-number":["CP08\/00140"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI 12\/00910"],"award-info":[{"award-number":["PI 12\/00910"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neubiorev.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T18:45:18Z","timestamp":1432579518000},"page":"403-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness"],"prefix":"10.1016","volume":"55","author":[{"given":"J.","family":"Le\u00f3n-Caballero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pacchiarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Murru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Valent\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Colom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Benach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0053","authenticated-orcid":false,"given":"E.","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2015.05.012_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here?","volume":"72","author":"Aan Het Rot","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0010","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1176\/ajp.150.11.1731","article-title":"Plasma and platelet excitatory amino acids in psychiatric disorders","volume":"150","author":"Altamura","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1399-5618.2011.00971.x","article-title":"Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial","volume":"14","author":"Anand","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0173(98)00050-2","article-title":"Metabotropic glutamate receptors: electrophysiological properties and role in plasticity","volume":"29","author":"Anwyl","year":"1999","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24083","article-title":"Herpes simplex virus encephalitis is a trigger of brain autoimmunity","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2217\/14796708.3.2.125","article-title":"Mania: a rational neurobiology","volume":"3","author":"Arnsten","year":"2008","journal-title":"Future Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0035","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/GIM.0b013e318159a37c","article-title":"Stage II follow-up on a linkage scan for bipolar disorder in the Ashkenazim provides suggestive evidence for chromosome 12p and the GRIN2B gene","volume":"9","author":"Avramopoulos","year":"2007","journal-title":"Genet. Med."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0040","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/sj.npp.1300920","article-title":"Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats","volume":"31","author":"Basselin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychires.2014.04.017","article-title":"Inflammatory mediators of cognitive impairment in bipolar disorder","volume":"56","author":"Bauer","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0050","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","article-title":"Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders","volume":"32","author":"Beneyto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biopsych.2013.09.023","article-title":"The epidemiologic evidence linking autoimmune diseases and psychosis","volume":"75","author":"Benros","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0060","first-page":"812","article-title":"Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study","volume":"70","author":"Benros","year":"2013","journal-title":"J. AM. MED. ASSOC. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0065","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1745-0179-3-31","article-title":"Affective psychosis, Hashimoto's thyroiditis, and brain perfusion abnormalities: case report","volume":"3","author":"Bocchetta","year":"2007","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0080","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/WNR.0000000000000268","article-title":"Lithium prevents aberrant NMDA-induced F-actin reorganization in neurons","volume":"25","author":"Calabrese","year":"2014","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1752-1947-4-337","article-title":"Hashimoto's encephalopathy presenting with neurocognitive symptoms: a case report","volume":"4","author":"Canelo-Aybar","year":"2010","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jad.2013.11.008","article-title":"The risk of bipolar disorders in multiple sclerosis","volume":"155","author":"Carta","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-244X-12-52","article-title":"Bipolar disorders and Wilson's disease","volume":"12","author":"Carta","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0100","first-page":"832","article-title":"Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations","volume":"21","author":"Castillo","year":"2000","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0105","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.euroneuro.2013.04.001","article-title":"The increasing burden of mental and neurological disorders","volume":"23","author":"Catal\u00e1-L\u00f3pez","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1176\/appi.ajp.2010.10020181","article-title":"Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment","volume":"168","author":"Chapman","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neulet.2012.10.060","article-title":"Anti-glutamate receptor \u025b2 antibodies in psychiatric patients with anti-thyroid autoantibodies\u2014a prevalence study in Japan","volume":"534","author":"Chiba","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/npp.2010.163","article-title":"Glutamatergic model psychoses: prediction error, learning, and inference","volume":"36","author":"Corlett","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neulet.2005.12.085","article-title":"Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes","volume":"398","author":"Cunha","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","article-title":"Brain metabolic alterations in medication-free patients with bipolar disorder","volume":"61","author":"Dager","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0135","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0145","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0150","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0155","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1399-5618.2012.01028.x","article-title":"Antibodies to the glutamate receptor in mania","volume":"14","author":"Dickerson","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0165","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1399-5618.2010.00853.x","article-title":"Autoimmune diseases, bipolar disorder, and non-affective psychosis","volume":"12","author":"Eaton","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2013.02.001","article-title":"Prevalence, chronicity, burden and borders of bipolar disorder","volume":"148","author":"Fagiolini","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0180","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2174\/138161212799958585","article-title":"The possible involvement of NMDA glutamate receptor in the etiopathogenesis of bipolar disorder","volume":"18","author":"Fountoulakis","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pscychresns.2006.11.003","article-title":"Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy","volume":"154","author":"Frye","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biopsych.2006.01.024","article-title":"Low cerebrospinal fluid glutamate and glycine in refractory affective disorder","volume":"61","author":"Frye","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature04089","article-title":"Subunit arrangement and function in NMDA receptors","volume":"438","author":"Furukawa","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0200","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project","volume":"54","author":"Gable","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0205","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neubiorev.2014.08.017","article-title":"The role of NMDA receptors in the pathophysiology and treatment of mood disorders","volume":"47C","author":"Ghasemi","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.mp.4001793","article-title":"Treatment-resistant bipolar disorder","volume":"11","author":"Gitlin","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0215","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/acps.12268","article-title":"Staging bipolar disorder: clinical, biochemical, and functional correlates","volume":"129","author":"Grande","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0220","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1034\/j.1399-5618.1999.010204.x","article-title":"Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder","volume":"1","author":"Hahn","year":"1999","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11920-013-0387-y","article-title":"Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications","volume":"15","author":"Hamdani","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0240","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0245","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0250","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.schres.2012.05.006","article-title":"Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic patients","volume":"140","author":"Haussleiter","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.euroneuro.2005.06.003","article-title":"Bipolar mania and plasma amino acids: increased levels of glycine","volume":"16","author":"Hoekstra","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0260","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2013.02.020","article-title":"Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression","volume":"74","author":"Huang","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0265","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0270","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0275","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(03)00501-9","article-title":"Genetic analysis of a functional GRIN2A promoter (GT)n repeat in bipolar disorder pedigrees in humans","volume":"345","author":"Itokawa","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0280","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1474-4422(08)70165-0","article-title":"NMDA receptors in clinical neurology: excitatory times ahead","volume":"7","author":"Kalia","year":"2008","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0285","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0290","article-title":"Anti-NMDA receptor encephalitis, autoimmunity, and psychosis","author":"Kayser","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0295","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1176\/appi.ajp.2010.09101547","article-title":"Psychiatric manifestations of paraneoplastic disorders","volume":"167","author":"Kayser","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0300","first-page":"1133","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti\u2013N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"J. Am. Med. Assoc. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0305","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.bbrc.2011.04.087","article-title":"Glutathione is a physiologic reservoir of neuronal glutamate","volume":"409","author":"Koga","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0310","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1399-5618.2010.00803.x","article-title":"Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder","volume":"12","author":"Koukopoulos","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0315","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2011.09.040","article-title":"The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial","volume":"136","author":"Koukopoulos","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0320","article-title":"Autoimmune encephalopathies","author":"Leypoldt","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0325","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJMcibr0902052","article-title":"Memory and the NMDA receptors","volume":"361","author":"Li","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2011.05.019","article-title":"Encephalopathy associated with autoimmune thyroid disease (Hashimoto's thyroiditis) presenting as depression: a case report","volume":"33","author":"Liu","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0335","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0340","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1192\/apt.bp.108.005785","article-title":"Clinical implications of neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Mak","year":"2009","journal-title":"Adv. Psychiatr. Treat."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0345","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fpsyt.2014.00098","article-title":"Integrated neurobiology of bipolar disorder","volume":"5","author":"Maletic","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0350","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/appi.ajp.2012.12050646","article-title":"Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia","volume":"169","author":"Masdeu","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0355","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4088\/JCP.13r08634","article-title":"Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression","volume":"75","author":"McElroy","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0360","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0365","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.biopsych.2012.09.006","article-title":"The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine","volume":"73","author":"Monteggia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0370","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ana.24195","article-title":"Acute mechanisms underlying antibody effects in anti-N-methyl-d-aspartate receptor encephalitis","volume":"76","author":"Moscato","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0375","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/13543784.2014.852536","article-title":"GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists","volume":"23","author":"Moskal","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0380","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.neuropharm.2005.06.006","article-title":"GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-d-aspartate receptor modulator","volume":"49","author":"Moskal","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0385","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.mp.4001218","article-title":"Evidence that the N-methyl-d-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder","volume":"8","author":"Mundo","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0390","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0395","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1399-5618.2005.00196.x","article-title":"Hashimoto's encephalopathy presenting with bipolar affective disorder","volume":"7","author":"M\u00fcssig","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0400","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.schres.2007.06.012","article-title":"Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder","volume":"95","author":"Palomino","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0405","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12031-011-9673-5","article-title":"Effect of valproic acid through regulation of NMDA receptor-ERK signaling in sleep deprivation rats","volume":"47","author":"Park","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0410","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.schres.2014.05.001","article-title":"Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder","volume":"157","author":"Pearlman","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0415","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl d-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planagum\u00e0","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0420","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1017\/S003329171300295X","article-title":"Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis","volume":"44","author":"Pollak","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0425","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/157015911796557984","article-title":"Neuropsychiatric systemic lupus erythematosus","volume":"9","author":"Popescu","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0430","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1017\/S1461145711001003","article-title":"Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder","volume":"15","author":"Ramadan","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0435","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/0004867413499077","article-title":"Immune dysregulation and autoimmunity in bipolar disorder: synthesis of the evidence and its clinical application","volume":"47","author":"Rege","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0440","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2010.12.018","article-title":"Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia","volume":"129","author":"Rhoads","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0445","first-page":"1","article-title":"Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels","author":"Rosa","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0450","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1176\/ajp.136.5.672","article-title":"Amino acids in bipolar affective disorders: increased glycine levels in erythrocytes","volume":"136","author":"Rosenblatt","year":"1979","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0455","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.euroneuro.2013.05.008","article-title":"Autoimmune-induced glutamatergic receptor dysfunctions: conceptual and psychiatric practice implications","volume":"23","author":"Rosenthal-Simons","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0460","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.2271","article-title":"Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?","volume":"28","author":"Rybakowski","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0465","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/mp.2013.130","article-title":"Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects","volume":"19","author":"Sanacora","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0470","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0475","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/08820139.2012.685537","article-title":"Spectrum of autoantibodies in Tunisian psychiatric inpatients","volume":"41","author":"Sidhom","year":"2012","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0480","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.neuroscience.2009.04.013","article-title":"Glutamate-mediated calcium signaling: a potential target for lithium action","volume":"161","author":"Sourial-Bassillious","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0485","first-page":"271","article-title":"Increased prevalence of diverse N-methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-d-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"J. Am. Med. Assoc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/09687680801971367","article-title":"Assembly and forward trafficking of NMDA receptors (Review)","volume":"25","author":"Stephenson","year":"2008","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0495","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuropharm.2008.08.015","article-title":"Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania","volume":"56","author":"Szabo","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0500","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1124\/jpet.103.052597","article-title":"Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment","volume":"306","author":"Tarazi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0505","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S1516-44462006000300020","article-title":"Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder","volume":"28","author":"Teng","year":"2006","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0510","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mds.25716","article-title":"Antibodies to N-methyl-d-aspartate and other synaptic receptors in choreoathetosis and relapsing symptoms post-herpes virus encephalitis","volume":"29","author":"Titulaer","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0515","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0520","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1212\/WNL.0b013e3182a4a49c","article-title":"Late-onset anti-NMDA receptor encephalitis","volume":"81","author":"Titulaer","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0525","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2005.07.003","article-title":"NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder","volume":"80","author":"Toro","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0530","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0535","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/sj.mp.4000447","article-title":"Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder","volume":"3","author":"Turecki","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0540","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1023\/A:1027377605054","article-title":"Glutathione is an endogenous ligand of rat brain N-methyl-d-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors","volume":"22","author":"Varga","year":"1997","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0545","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuint.2014.09.007","article-title":"NMDA receptor dysregulation in chronic state: a possible mechanism underlying depression with BDNF downregulation","volume":"79C","author":"V\u00e1squez","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0550","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0000000000000126","article-title":"Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis","volume":"82","author":"Viaccoz","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0555","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1017\/S1461145713000278","article-title":"Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd)","volume":"16","author":"Vieta","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0560","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40263-013-0073-y","article-title":"Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis","volume":"27","author":"Vieta","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0565","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ana.20614","article-title":"Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma","volume":"58","author":"Vitaliani","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0570","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0006-3223(95)00611-7","article-title":"Enhanced protein kinase C activity and translocation in bipolar affective disorder brains","volume":"40","author":"Wang","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0575","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0580","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00415-010-5788-9","article-title":"Disease-relevant autoantibodies in first episode schizophrenia","volume":"258","author":"Zandi","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0585","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/10673229.2010.511059","article-title":"Glutamatergic modulators: the future of treating mood disorders?","volume":"18","author":"Zarate","year":"2010","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0590","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0595","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.expneurol.2008.01.011","article-title":"The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases","volume":"211","author":"Zarate","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0600","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopsych.2012.10.019","article-title":"A randomized trial of a low-trapping nonselective N-methyl-d-aspartate channel blocker in major depression","volume":"74","author":"Zarate","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0605","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0610","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Zarate","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.012_bib0615","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.neuropharm.2009.07.019","article-title":"The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist","volume":"57","author":"Zhang","year":"2009","journal-title":"Neuropharmacology"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415001384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415001384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T07:33:35Z","timestamp":1655624015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763415001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":123,"alternative-id":["S0149763415001384"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2015.05.012","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}